Multicenter safety study of perilesional application of CIGB-128A in skin carcinomas eyelid with surgical risk and aesthetic implications.

Trial Profile

Multicenter safety study of perilesional application of CIGB-128A in skin carcinomas eyelid with surgical risk and aesthetic implications.

Not yet recruiting
Phase of Trial: Phase I

Latest Information Update: 06 Sep 2016

At a glance

  • Drugs Interferon-alpha-2b/interferon-gamma (Primary)
  • Indications Skin cancer
  • Focus Adverse reactions
  • Acronyms SCIENCE
  • Most Recent Events

    • 06 Sep 2016 Status changed from planning to not yet recruiting.
    • 18 Feb 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top